SCHEMBL31664088

SCHEMBL31664088

CCOC(=O)COCCOCCn1ccc2c(N)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.42
▸ CREBBP Q92793 1/20 0.41
▸ PARP1 P09874 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TUBB4A P04350 1/20 0.37
▸ TUBB P07437 1/20 0.37
▸ TUBA3C P0DPH7 1/20 0.37
▸ TUBA1B P68363 1/20 0.37
▸ TUBA4A P68366 1/20 0.37
▸ TUBB4B P68371 1/20 0.37
▸ TUBB3 Q13509 1/20 0.37
▸ TUBB2A Q13885 1/20 0.37
▸ TUBB8 Q3ZCM7 1/20 0.37
▸ TUBA3E Q6PEY2 1/20 0.37
▸ TUBA1A Q71U36 1/20 0.37
▸ TUBA1C Q9BQE3 1/20 0.37
▸ TUBB6 Q9BUF5 1/20 0.37
▸ TUBB2B Q9BVA1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21070695 1.00 KDM4E (0.42) KDM4ECREBBPPARP1HRH1ALDH1A1
SCHEMBL21070262 0.84 PARP1 (0.46) CREBBPPARP1LMNAMCL1
SCHEMBL21070644 0.83 ALDH1A1 (0.40) KDM4ECREBBPHRH1ALDH1A1LMNA
SCHEMBL3913002 0.80 ALDH1A1 (0.52) KDM4ECREBBPALDH1A1LMNAMAPT
SCHEMBL29612923 0.80 ALDH1A1 (0.52) KDM4ECREBBPALDH1A1LMNAMAPT
SCHEMBL14671387 0.80 HTR2C (0.38) PARP1LMNAMCL1
SCHEMBL20945102 0.80 TNF (0.42) KDM4EPARP1HRH1ALDH1A1LMNA
Ethoxycarbonyl Group SCHEMBL27492236 0.79 CREBBP (0.42) KDM4ECREBBPHRH1ALDH1A1LMNA
SCHEMBL21071403 0.79 PARP1 (0.41) PARP1LMNAMCL1
SCHEMBL27611518 0.78 PARP1 (0.43) CREBBPPARP1ALDH1A1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4613773-A2 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
EP-3731869-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-07-23 — — EP disclosed
Send feedback